BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 29201499)

  • 1. Biparametric MRI of the prostate.
    Scialpi M; D'Andrea A; Martorana E; Malaspina CM; Aisa MC; Napoletano M; Orlandi E; Rondoni V; Scialpi P; Pacchiarini D; Palladino D; Dragone M; Di Renzo G; Simeone A; Bianchi G; Brunese L
    Turk J Urol; 2017 Dec; 43(4):401-409. PubMed ID: 29201499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Biparametric and Multiparametric MRI for Clinically Significant Prostate Cancer Detection With PI-RADS Version 2.1.
    Tamada T; Kido A; Yamamoto A; Takeuchi M; Miyaji Y; Moriya T; Sone T
    J Magn Reson Imaging; 2021 Jan; 53(1):283-291. PubMed ID: 32614123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of biparametric and multiparametric MRI in the diagnosis of prostate cancer.
    Xu L; Zhang G; Shi B; Liu Y; Zou T; Yan W; Xiao Y; Xue H; Feng F; Lei J; Jin Z; Sun H
    Cancer Imaging; 2019 Dec; 19(1):90. PubMed ID: 31864408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Head-to-head comparison of biparametric versus multiparametric MRI of the prostate before robot-assisted transperineal fusion prostate biopsy.
    Thaiss WM; Moser S; Hepp T; Kruck S; Rausch S; Scharpf M; Nikolaou K; Stenzl A; Bedke J; Kaufmann S
    World J Urol; 2022 Oct; 40(10):2431-2438. PubMed ID: 35922717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate cancer detection with biparametric magnetic resonance imaging (bpMRI) by readers with different experience: performance and comparison with multiparametric (mpMRI).
    Gatti M; Faletti R; Calleris G; Giglio J; Berzovini C; Gentile F; Marra G; Misischi F; Molinaro L; Bergamasco L; Gontero P; Papotti M; Fonio P
    Abdom Radiol (NY); 2019 May; 44(5):1883-1893. PubMed ID: 30788558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is contrast enhancement needed for diagnostic prostate MRI?
    Scialpi M; Rondoni V; Aisa MC; Martorana E; D'Andrea A; Malaspina CM; Orlandi A; Galassi G; Orlandi E; Scialpi P; Dragone M; Palladino D; Simeone A; Amenta M; Bianchi G
    Transl Androl Urol; 2017 Jun; 6(3):499-509. PubMed ID: 28725592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prebiopsy Biparametric MRI for Clinically Significant Prostate Cancer Detection With PI-RADS Version 2: A Multicenter Study.
    Choi MH; Kim CK; Lee YJ; Jung SE
    AJR Am J Roentgenol; 2019 Apr; 212(4):839-846. PubMed ID: 30779662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthetic magnetic resonance imaging for primary prostate cancer evaluation: Diagnostic potential of a non-contrast-enhanced bi-parametric approach enhanced with relaxometry measurements.
    Arita Y; Akita H; Fujiwara H; Hashimoto M; Shigeta K; Kwee TC; Yoshida S; Kosaka T; Okuda S; Oya M; Jinzaki M
    Eur J Radiol Open; 2022; 9():100403. PubMed ID: 35242886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic value of integrated
    Zeng Y; Leng X; Liao H; Jiang G; Chen P
    Prostate Int; 2022 Jun; 10(2):108-116. PubMed ID: 35510079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic accuracy of biparametric versus multiparametric prostate MRI: assessment of contrast benefit in clinical practice.
    Zawaideh JP; Sala E; Shaida N; Koo B; Warren AY; Carmisciano L; Saeb-Parsy K; Gnanapragasam VJ; Kastner C; Barrett T
    Eur Radiol; 2020 Jul; 30(7):4039-4049. PubMed ID: 32166495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biparametric vs multiparametric prostate magnetic resonance imaging for the detection of prostate cancer in treatment-naïve patients: a diagnostic test accuracy systematic review and meta-analysis.
    Alabousi M; Salameh JP; Gusenbauer K; Samoilov L; Jafri A; Yu H; Alabousi A
    BJU Int; 2019 Aug; 124(2):209-220. PubMed ID: 30929292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing biparametric to multiparametric MRI in the diagnosis of clinically significant prostate cancer in biopsy-naive men (PRIME): a prospective, international, multicentre, non-inferiority within-patient, diagnostic yield trial protocol.
    Asif A; Nathan A; Ng A; Khetrapal P; Chan VW; Giganti F; Allen C; Freeman A; Punwani S; Lorgelly P; Clarke CS; Brew-Graves C; Muirhead N; Emberton M; Agarwal R; Takwoingi Y; Deeks JJ; Moore CM; Kasivisvanathan V;
    BMJ Open; 2023 Apr; 13(4):e070280. PubMed ID: 37019486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biparametric versus Multiparametric Magnetic Resonance Imaging for Assessing Muscle Invasion in Bladder Urothelial Carcinoma with Variant Histology Using the Vesical Imaging-Reporting and Data System.
    Arita Y; Kwee TC; Woo S; Shigeta K; Ishii R; Okawara N; Edo H; Waseda Y; Vargas HA
    Eur Urol Focus; 2024 Jan; 10(1):131-138. PubMed ID: 37633790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of multiparametric and biparametric MRI of the prostate: are gadolinium-based contrast agents needed for routine examinations?
    Junker D; Steinkohl F; Fritz V; Bektic J; Tokas T; Aigner F; Herrmann TRW; Rieger M; Nagele U
    World J Urol; 2019 Apr; 37(4):691-699. PubMed ID: 30078170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Score 3 prostate lesions: a gray zone for PI-RADS v2.
    Scialpi M; Martorana E; Aisa MC; Rondoni V; D'Andrea A; Bianchi G
    Turk J Urol; 2017 Sep; 43(3):237-240. PubMed ID: 28861291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simplified PI-RADS (S-PI-RADS) for biparametric MRI to detect and manage prostate cancer: What urologists need to know.
    Scialpi M; Scialpi P; Martorana E; Torre R; Improta A; Aisa MC; D'Andrea A; Di Blasi A
    Turk J Urol; 2021 May; 47(3):175-182. PubMed ID: 35929870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The diagnostic performance in clinically significant prostate cancer with PI-RADS version 2.1: simplified bpMRI versus standard mpMRI.
    Song J; Zhao C; Zhang F; Yuan Y; Wang LM; Sah V; Zhang J; Weng W; Yang Z; Wang Z; Wang L
    Abdom Radiol (NY); 2023 Feb; 48(2):704-712. PubMed ID: 36464756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Utility of Combined Target and Systematic Prostate Biopsies in the Diagnosis of Clinically Significant Prostate Cancer Using Prostate Imaging Reporting and Data System Version 2 Based on Biparametric Magnetic Resonance Imaging.
    Kato D; Ozawa K; Takeuchi S; Kawase M; Kawase K; Nakai C; Takai M; Iinuma K; Nakane K; Kato H; Matsuo M; Suzui N; Miyazaki T; Koie T
    Curr Oncol; 2021 Mar; 28(2):1294-1301. PubMed ID: 33809967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison between biparametric and multiparametric MRI diagnosis strategy for prostate cancer in the peripheral zone using PI-RADS version 2.1.
    Zhang J; Xu L; Zhang G; Zhang X; Bai X; Ji Z; Xiao Y; Sun H; Jin Z
    Abdom Radiol (NY); 2022 Aug; 47(8):2905-2916. PubMed ID: 35622121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate Imaging Reporting and Data System (PI-RADS): What the radiologists need to know?
    Razek AAKA; El-Diasty T; Elhendy A; Fahmy D; El-Adalany MA
    Clin Imaging; 2021 Nov; 79():183-200. PubMed ID: 34098371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.